REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharms Ville Co.,Ltd. (South Korea)

Main Activities: All Other Miscellaneous Food Manufacturing
Full name: Pharms Ville Co.,Ltd. Profile Updated: July 04, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Pharms Ville Co.,Ltd. is engaged in provision of health food. The company also manufactures and sells lutein products as well as belgian probiotics diet, oatmeal, berry freeze-drying powder, collagen products, and other products. Pharms Ville Co.,Ltd. was incorporated in 2000 and is based in Seoul, South Korea.

Headquarters
37, Magok 8-ro 3-gil Gangseo-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Pharms Ville Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Pharms Ville Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Pharms Ville Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Pharms Ville Co.,Ltd. report to view the information.
Incorporation Date:
March 15, 2000
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Senior Managing Director
Purchase this report to view the information.
Executive Director
Company Performance
Financial values in the chart are available after Pharms Ville Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-33.2%▼
Total operating revenue
-33.2%▼
Operating profit (EBIT)
-34.7%▼
EBITDA
-33.7%▼
Net Profit (Loss) for the Period
-19.6%▼
Total assets
0.71%▲
Total equity
5.63%▲
Operating Profit Margin (ROS)
-0.36%▼
Net Profit Margin
2.64%▲
Return on Equity (ROE)
-2.03%▼
Debt to Equity Ratio
-3.18%▼
Quick Ratio
0.38%▲
Cash Ratio
0.69%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo